The industry has pivoted to rare disease and oncology, but the infrastructure for finding patients and sites has not kept pace.
A SaaS platform that unifies protocol intelligence, site matching, and study activation into a single automated workflow.
Three automated stages eliminate the manual labor that stalls study startup.
Active pilot with a clinical research client demonstrating full platform capability at production scale.
Incumbents address pieces of the problem. We are the first to unify all five capabilities in one solution.
| Protocol Intelligence | Site Matching | Feasibility Automation | Marketplace | Study Startup | |
|---|---|---|---|---|---|
| Medidata Rave | ~ | ~ | -- | -- | ~ |
| Veeva SiteVault | -- | ~ | -- | -- | ~ |
| Deep 6 AI | ~ | ~ | -- | -- | -- |
| TriNetX | -- | ~ | -- | -- | -- |
| Research Lambda | ✓ | ✓ | ✓ | ✓ | ✓ |
✓ Full ~ Partial -- Not offered
The global clinical trials market is projected to reach $110B by 2030. Research Lambda targets the $5B+ trial intelligence layer within this market. The top 50 CROs control 80% of the market, making a focused enterprise go-to-market strategy highly efficient.
